Yuta Adachi

Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies

Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways

Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C–Mutant Non–Small Cell Lung Cancer

Epithelial-to-Mesenchymal Transition Defines Feedback Activation of Receptor Tyrosine Kinase Signaling Induced by MEK Inhibition in KRAS -Mutant Lung Cancer